1-10 of 10
molecular targeted therapy
Close
Sort by
Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Clinical Trials & Observations
Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1899–1902.
https://doi.org/10.1182/bloodadvances.2020003699
Published: 2021
Journal Articles

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia

Haesook T. Kim, Conner J. Shaughnessy, Sharmila C. Rai, Carol Reynolds, Vincent T. Ho, Corey Cutler, John Koreth, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, Philippe Armand, Edwin P. Alyea, Joseph H. Antin, Catherine J. Wu, Robert J. Soiffer, Jerome Ritz, Jennifer R. Brown
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4113–4123.
https://doi.org/10.1182/bloodadvances.2020002184
Published: 2020
Includes: Supplemental data
Journal Articles

Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Clinical Trials & Observations
Marilyn J. Telen
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3457–3465.
https://doi.org/10.1182/bloodadvances.2020001469
Published: 2020
Journal Articles

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

Lynn H. Lee, Christa Krupski, Jason Clark, Mark Wunderlich, Robert B. Lorsbach, Michael S. Grimley, Matthew Burwinkel, Adam Nelson, Ashish R. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (4): 717–727.
https://doi.org/10.1182/bloodadvances.2019032367
Published: 2020
Includes: Supplemental data
Journal Articles

Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD + AML

Silvia Masciarelli, Ernestina Capuano, Tiziana Ottone, Mariadomenica Divona, Serena Lavorgna, Francesca Liccardo, Martyna Śniegocka, Serena Travaglini, Nelida I. Noguera, Alessandra Picardi, Vincenzo Petrozza, Alessandro Fatica, Luca Tamagnone, Maria Teresa Voso, Francesco Lo Coco, Francesco Fazi
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4155–4160.
https://doi.org/10.1182/bloodadvances.2019000540
Published: 2019
Includes: Supplemental data
Journal Articles

Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion

Tomohiro Umezu, Satoshi Imanishi, Seiichiro Yoshizawa, Chiaki Kawana, Junko H. Ohyashiki, Kazuma Ohyashiki
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3228–3240.
https://doi.org/10.1182/bloodadvances.2019000403
Published: 2019
Includes: Supplemental data
Journal Articles

Hematopoietic cytokines mediate resistance to targeted therapy in FLT3-ITD acute myeloid leukemia

Pamela J. Sung, Mayumi Sugita, Holly Koblish, Alexander E. Perl, Martin Carroll
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1061–1072.
https://doi.org/10.1182/bloodadvances.2018029850
Published: 2019
Includes: Supplemental data
Journal Articles

Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

Clinical Trials & Observations
Alex Aleshin, Peter L. Greenberg
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2787–2797.
https://doi.org/10.1182/bloodadvances.2018015834
Published: 2018
Journal Articles

The role of targeted therapy in the management of patients with AML

Clinical Trials & Observations
Alexander E. Perl
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2281–2294.
https://doi.org/10.1182/bloodadvances.2017009829
Published: 2017
Journal Articles

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia

Lynn Quek, Paul Ferguson, Marlen Metzner, Ikhlaaq Ahmed, Alison Kennedy, Catherine Garnett, Sally Jeffries, Claudia Walter, Kim Piechocki, Adele Timbs, Robert Danby, Manoj Raghavan, Andrew Peniket, Mike Griffiths, Andrew Bacon, Janice Ward, Keith Wheatley, Paresh Vyas, Charles Craddock
Journal: Blood Advances
Blood Adv (2016) 1 (3): 193–204.
https://doi.org/10.1182/bloodadvances.2016000760
Published: 2016
Includes: Supplemental data